Position in AVXL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,136
-$766 QoQ
Shares Held
1,597
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#149
of 179 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kilter Group LLC holds $136,608 across 30 Biotechnology names. AVXL ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122 | $60,601 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28 | $17,459 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
114 | $8,922 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
73 | $5,954 | |
| 5 | RPRX |
Royalty Pharma plc
|
89 | $4,990 | |
| 6 | GMAB |
Genmab A/S
|
179 | $4,917 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
This page
|
1,597 | $4,136 |
All Filings in AVXL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,136 | 1,597 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,902 | 1,597 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,685 | 1,597 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,213 | 1,597 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $14,724 | 1,597 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||